DIGILAB'S PREP SERVICES USED FOR DIABETES RESEARCH.A recent publication in a biotech journal acknowledges a Top 10 pharmaceutical company has utilized Digilab's sample preparation and fractionation fractionation /frac·tion·a·tion/ (frak?shun-a´shun) 1. in radiology, division of the total dose of radiation into small doses administered at intervals. 2. technologies to expose standard and novel diabetes substrates in a Fourier Transform Fourier transform In mathematical analysis, an integral transform useful in solving certain types of partial differential equations. A function's Fourier transform is derived by integrating the product of the function and a kernel function (an exponential function raised to Mass Spectroscopy mass spectroscope n. Any of various devices that use magnetic fields, electric fields, or both to determine the masses of isotopes in a sample by producing a mass spectrum. experimental paradigm (Yates, et al., 2007). "We evaluated reproducible sample preparation methodologies that could generate pools of candidate substrates for interrogation interrogation In criminal law, process of formally and systematically questioning a suspect in order to elicit incriminating responses. The process is largely outside the governance of law, though in the U.S. against any target protease protease /pro·te·ase/ (pro´te-as) endopeptidase. pro·te·ase n. Any of various enzymes, including the proteinases and peptidases, that catalyze the hydrolytic breakdown of proteins. of interest. Fractionation technology from Digilab Biovision GmbH, Hanover, Germany, was adopted for the isolation of low molecular weight peptides (typically <15,000 Da) from human plasma ultrafiltrate." N.A. Yates et al., Int. J. Mass Spectrom. (2006), doi:10.1016/j.ijms.2006.09.020 Digilab's sample preparation procedure offered provided a high enrichment of peptides in biological samples while eliminating high molecular weight protein content, thus enabling a uniquely high sensitivity for peptides in mass spectrometric analyses. Details of the service offer can be found on the website of Digilab "peptidomics.com" http://www.biovision-discovery.de/content/peptide_extraction_services.htm David Giddings, president and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Digilab, Inc. commented on the publication: "We are pleased our peptidomics sample prep services have proven so beneficial to drug discovery and development work. We look forward to extending these services to other Digilab life sciences industry". About Digilab As a global leader in molecular spectroscopy systems for almost 40 years, Digilab develops innovative and differentiated products and services for the life sciences research and in-vitro diagnostics markets. The company's pioneering work for the U.S. Government in 1969 led to the development, manufacture, sales and service of the first commercial Fourier-Transform InfraRed (FTIR FTIR Fourier Transform Infrared (spectroscopy) FTIR Frustrated Total Internal Reflection FTIR Fourier Transfer Ir ) spectrometer. In the fall of 2004, Digilab sold its FTIR molecular spectroscopy assets to Varian Inc. Since then, the company has remained focused on novel and proprietary sample prep, bioinformatics, and spectroscopy detection/analysis devices that can be integrated into solutions for research and diagnostics applications. In February 2006 Digilab acquired BioVisioN, AG in Hannover, Germany. Digilab is globally commercializing Digilab BioVisioN GmbH's patented Peptidomics(R) products and services and generating IP in this space. Digilab works with companies from the pharmaceutical and diagnostics sectors; analytical instrumentation hardware, software, and consumables suppliers; and academic institutions and government agencies. Digilab has had engagements to discover new biomarkers or drug targets with Astra Zeneca, Boehringer Ingelheim, Novartis, Novo Nordisk Wikipedia is not the place for advertisement or self-advertising. Novo Nordisk (, NYSE: NVO) manufactures and markets pharmaceutical products and services. Founded in Denmark in 1923, the company has since become a world leader in diabetes care with the broadest , Roche Diagnostics, Abbott Laboratories, Johnson and Johnson, and Solvay Pharmaceuticals. For more information, visit http://www.digilabglobal.com or call 781/575-0310 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion